傲農生物(603363.SH):傲新華富擬出售高橋養殖場及雪山養殖場相關資產
格隆匯10月12日丨傲農生物(603363.SH)公佈,公司子公司福建傲農畜牧投資有限公司的控股子公司井岡山市傲新華富育種有限公司(以下簡稱“傲新華富”)擬將其擁有的高橋養殖場、雪山養殖場的固定資產、設備等出售給江西傲楚農牧有限責任公司(以下簡稱“江西傲楚”),轉讓金額為人民幣3404.29萬元。
傲新華富本次轉讓資產的主要原因是上述位於永新高橋和泰和雪山林場的養殖基地相對老舊,改造難度大、成本高,持續經營壓力較大,同時公司在永新縣和泰和縣建有新的高標準養殖基地,擬以新產能替換上述舊產能,因此擬轉讓上述資產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.